[1] 徐兵河. 复发转移乳腺癌的化学治疗[J].中国实用内科杂志,2007,27(3): 24-26. [2] Burstein H. The distinctive nature of HER2-positive breast cancers[J]. New Engl J Med, 2006, 353(16):1652-1654. [3] Rubin CI, Atweh GF. The role of stathmin in the regulation of the cell cycle[J]. J Cell Biochem,2004,93(2):242-250. [4] Jeha S,Luo XN,Beran M,et al.Antisense RNA inhibition of phosphoprotein p18 expression abrogates the transformed phenotype of leukemic cells[J].Cancer Res,2006,56(6):1445-1450. [5] Zhang HZ,Wang Y,Gao P,et al.Silencing stathmin gene expression by survivin promoter-driven siRNA vector to reverse malignant phenotype of tumor cells[J].Cancer Biol Ther, 2006,5(11): 1457-1641. [6] Milross CG, Mason KA, Hunter NR, et al. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel[J]. J Natl Cancer Inst, 1996,88(18):1308-1314. [7] 原少斐,陈筱婷,汪森明,等.抗人微管不稳定蛋白单克隆抗体的制备及鉴定[J].肿瘤防治研究,2009,36(6):18-22. [8] Cassimers L.The op18/stathmin family of microtubule destabilizers[J].Curr Opin Cell Bio, 2002,14(1):18-24. [9] Gadea BB,Ruderman JV.Aurora B is required for mitotic chromatininduced phosphorylation of Op18/Stathmin[J]. Proc Natl Acad Sci USA, 2006,103(12):449. [10] Tuschl T, Borkhardt A. Small interfering RNAs:a revolutionary tool for the analysis of gene function and gene therapy[J]. Mol Interv, 2002,2(3):158-167. [11] Hainsworth JD,Sosman JA,Spigel DR,et al.Phase II trial of bevacizumab and erlotinib in patients with metastatic renal carcinoma (RCC) [J]. Pro Am Soc Clin Oncol, 2004,22:382. [12] 武晓静,葛均波,黄岚,等.紫杉醇对兔血管内皮和平滑肌细胞增生影响的差异及意义[J].中国临床药理学与治疗学, 2006,11(8):902-906. |